CU23844B1 - Procedimiento de obtención de nuevos derivados de naftaleno para el diagnóstico in vivo de la enfermedad de alzheimer - Google Patents
Procedimiento de obtención de nuevos derivados de naftaleno para el diagnóstico in vivo de la enfermedad de alzheimerInfo
- Publication number
- CU23844B1 CU23844B1 CU2009000057A CU20090057A CU23844B1 CU 23844 B1 CU23844 B1 CU 23844B1 CU 2009000057 A CU2009000057 A CU 2009000057A CU 20090057 A CU20090057 A CU 20090057A CU 23844 B1 CU23844 B1 CU 23844B1
- Authority
- CU
- Cuba
- Prior art keywords
- alkylene
- alkyl
- halide
- compounds
- arylsulfonate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0446—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C233/07—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/35—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/36—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/25—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Esta invención se relaciona con la rama de la química, en particular con el campo de la síntesis orgánica de compuestos que pertenecen a la categoría de aromáticos bicíclicos o naftalénicos, utilizados en la detección de placas amiloideas. Estos nuevos derivados de naftaleno tienen fórmula general: ESPACIO PARA FÓRMULA Donde R representa a grupos independientes entre sí. En I: R1: -alquilenil-C(O)NH-alquilenil-R3, -alquilenil-C(O)O-R4; R3: -COOH, -OH, -SH, -NH2, -alquil-NH, -alquil-N-ditiocarbamato de sales de metales alcalino térreo; R4: H, grupo succinimido; R2: -H,-alquil. En II: R1: -alquilo, -alquilenil-haluro, -alquilenil-hidroxilo, -alquilenil-O-arilsulfonato, alquilenil-O-alquilsulfonato; R2: haluro, -alquilenil-O-arilsulfonato, -alquilenil-O-alquilsulfonato, -alquilenil-haluro, -CH(O), -HC=CHNO2, -alquilenil-NH2, -alquilenil-NH-alquil, -alquilenil-alquil-N-ditiocarbamato de sales alcalinas. Los terminos "alquil" y "alquileni"l se refieren a cadenas alifáticas lineales o ramificadas, prepferentemente de 1 a 4 átomos de carbono y el término haluro a Flúor, Bromo o Yodo. Estos compuestos son neutros, lipofílicos y de bajo peso molecular por lo que atraviesan la barrera hematoencefálica y se adhieren a las placas amiloideas. La presente invención proporciona los procedimientos para la obtención de derivados de naftaleno con buenos rendimientos, que pueden ser prácticos, económicos y ser adaptados a una manufactura a mayor escala. No tenemos conocimiento de que los compuestos presentados en esta invención hayan sido reportados anteriormente.
Priority Applications (21)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU2009000057A CU23844B1 (es) | 2009-04-17 | 2009-04-17 | Procedimiento de obtención de nuevos derivados de naftaleno para el diagnóstico in vivo de la enfermedad de alzheimer |
PT107641193T PT2436666E (pt) | 2009-04-17 | 2010-04-17 | Processo para obter novos derivados de naftalina para o diagnóstico in vivo da doença de alzheimer |
ES14075021.7T ES2692072T3 (es) | 2009-04-17 | 2010-04-17 | Procedimiento de obtención de nuevos derivados de naftaleno para el diagnóstico in vivo de la enfermedad de Alzheimer |
MYPI2012003534A MY162719A (en) | 2009-04-17 | 2010-04-17 | Method for obtaining novel derivatives of naphthalene for the in vivo diagnosis of alzheimer's disease |
PCT/CU2010/000001 WO2010118706A2 (es) | 2009-04-17 | 2010-04-17 | Procedimiento de obtención de nuevos derivados de naftaleno para el diagnóstico in vivo de la enfermedad de alzheimer |
CA2789869A CA2789869C (en) | 2009-04-17 | 2010-04-17 | Method for obtaining novel derivatives of naphthalene for the in vivo diagnosis of alzheimer's disease |
ES10764119.3T ES2478442T3 (es) | 2009-04-17 | 2010-04-17 | Procedimiento de obtención de nuevos derivados de naftaleno para el diagnóstico in vivo de la enfermedad de Alzheimer |
BRPI1014595-8A BRPI1014595B1 (pt) | 2009-04-17 | 2010-04-17 | Compostos derivados de naftaleno e procedimento para preparação dos mesmos |
PL10764119T PL2436666T3 (pl) | 2009-04-17 | 2010-04-17 | Sposób otrzymywania nowych pochodnych naftalenu do diagnostyki choroby Alzheimera in vivo |
DK10764119.3T DK2436666T3 (da) | 2009-04-17 | 2010-04-17 | Metode til at finde nye derivater af naftalin til in vivo diagnose af alzheimers sygdom |
BR122020016643A BR122020016643B8 (pt) | 2009-04-17 | 2010-04-17 | compostos derivados de naftaleno, procedimento para a preparação de derivados de alquilfluoronaftaleno e procedimento para marcação dos compostos com 99mtc |
MX2013011331A MX338943B (es) | 2009-04-17 | 2010-04-17 | Procedimiento de obtencion de nuevos derivados de naftaleno para el diagnostico in vivo de la enfermedad de alzheimer. |
US13/574,050 US9764047B2 (en) | 2009-04-17 | 2010-04-17 | Method for obtaining novel derivatives of naphthalene for the in vivo diagnosis of alzheimer's disease |
EP14075021.7A EP2860169B1 (en) | 2009-04-17 | 2010-04-17 | Method for obtaining novel derivatives of naphtalene for the in vivo diagnosis of Alzheimer's disease |
SI201030668T SI2436666T1 (sl) | 2009-04-17 | 2010-04-17 | Postopek za pridobivanje novih derivatov naftalena za diagnozo alzheimerjeve bolezni in vivo |
MX2011013405A MX2011013405A (es) | 2009-04-17 | 2010-04-17 | Procedimiento de obtencion de nuevos derivados de naftaleno para el diagnostico in vivo de la enfermedad de alzheimer. |
HUE14075021A HUE042030T2 (hu) | 2009-04-17 | 2010-04-17 | Eljárás újfajta naftalénszármazékok kinyerésére Alzheimer-kór in vivo megállapításához |
EP10764119.3A EP2436666B1 (en) | 2009-04-17 | 2010-04-17 | Method for obtaining novel derivatives of naphtalene for the in vivo diagnosis of alzheimer 's disease |
HRP20140628AT HRP20140628T1 (hr) | 2009-04-17 | 2014-07-01 | Metoda za dobivanje novih derivata naftalena za dijagnosticiranje alzheimerove bolesti in vivo |
SM201400118T SMT201400118B (it) | 2009-04-17 | 2014-08-29 | Metodo per ottenere nuovi derivati naftalenici perla diagnosi in vivo della malattia di alzheimer |
US14/636,316 US10155053B2 (en) | 2009-04-17 | 2015-03-03 | Method for obtaining novel derivatives of naphthalene for the in vivo diagnosis of Alzheimer's disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU2009000057A CU23844B1 (es) | 2009-04-17 | 2009-04-17 | Procedimiento de obtención de nuevos derivados de naftaleno para el diagnóstico in vivo de la enfermedad de alzheimer |
Publications (2)
Publication Number | Publication Date |
---|---|
CU20090057A6 CU20090057A6 (es) | 2011-10-14 |
CU23844B1 true CU23844B1 (es) | 2012-10-15 |
Family
ID=45000046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CU2009000057A CU23844B1 (es) | 2009-04-17 | 2009-04-17 | Procedimiento de obtención de nuevos derivados de naftaleno para el diagnóstico in vivo de la enfermedad de alzheimer |
Country Status (16)
Country | Link |
---|---|
US (2) | US9764047B2 (es) |
EP (2) | EP2860169B1 (es) |
BR (2) | BR122020016643B8 (es) |
CA (1) | CA2789869C (es) |
CU (1) | CU23844B1 (es) |
DK (1) | DK2436666T3 (es) |
ES (2) | ES2692072T3 (es) |
HR (1) | HRP20140628T1 (es) |
HU (1) | HUE042030T2 (es) |
MX (2) | MX2011013405A (es) |
MY (1) | MY162719A (es) |
PL (1) | PL2436666T3 (es) |
PT (1) | PT2436666E (es) |
SI (1) | SI2436666T1 (es) |
SM (1) | SMT201400118B (es) |
WO (1) | WO2010118706A2 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CU20130027A7 (es) * | 2013-02-28 | 2014-10-30 | Ct De Neurociencias De Cuba | Chaperoninas químicas como nuevos moduladores moleculares de la beta agregación proteica presente en las enfermedades conformacionales |
WO2015200187A1 (en) | 2014-06-27 | 2015-12-30 | Reiley Pharmaceuticals, Inc. | Conjugates derived from non-steroidal anti-inflammatory drugs and methods of use thereof in imaging |
EP3242688B1 (en) | 2015-01-09 | 2020-01-29 | Reiley Pharmaceuticals, Inc. | Cox-2-targeting, platinum-containing conjugates and their use in the treatment of tumors and cancers |
CU24583B1 (es) * | 2018-11-06 | 2022-02-04 | Centro De Neurociencias De Cuba | Nanopartículas de óxido metálicos conjugados con derivados de naftaleno como agentes de contrastes para la detección de placas amiloides por resonancia magnética (mri) |
US12017506B2 (en) | 2020-08-20 | 2024-06-25 | Denso International America, Inc. | Passenger cabin air control systems and methods |
US11636870B2 (en) | 2020-08-20 | 2023-04-25 | Denso International America, Inc. | Smoking cessation systems and methods |
US11760169B2 (en) | 2020-08-20 | 2023-09-19 | Denso International America, Inc. | Particulate control systems and methods for olfaction sensors |
US11828210B2 (en) | 2020-08-20 | 2023-11-28 | Denso International America, Inc. | Diagnostic systems and methods of vehicles using olfaction |
US11932080B2 (en) | 2020-08-20 | 2024-03-19 | Denso International America, Inc. | Diagnostic and recirculation control systems and methods |
US11881093B2 (en) | 2020-08-20 | 2024-01-23 | Denso International America, Inc. | Systems and methods for identifying smoking in vehicles |
US11760170B2 (en) | 2020-08-20 | 2023-09-19 | Denso International America, Inc. | Olfaction sensor preservation systems and methods |
US11813926B2 (en) | 2020-08-20 | 2023-11-14 | Denso International America, Inc. | Binding agent and olfaction sensor |
CU20200087A7 (es) | 2020-11-24 | 2022-07-08 | Centro De Neurociencias De Cuba | Composición farmacéutica de derivados de naftaleno como agentes terapéuticos multiblancos para el tratamiento de la enfermedad de alzheimer |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2976305A (en) * | 1958-07-30 | 1961-03-21 | Albert Ag Chem Werke | Salts of dithiocarbamic acids derived from amino amides of dicarboxylic acids |
US4327022A (en) * | 1973-08-16 | 1982-04-27 | Sterling Drug Inc. | Heterocyclic alkyl naphthols |
US4615876A (en) | 1983-04-25 | 1986-10-07 | Curators Of The University Of Missouri | Macrocyclic complexes of technetium-99m for use as diagnostic radionuclides |
EP0194843B1 (en) | 1985-03-11 | 1993-01-13 | AMERSHAM INTERNATIONAL plc | Complexes of technetium-99m with propylene amine oximes |
GB8601003D0 (en) | 1986-01-16 | 1986-02-19 | Amersham Int Plc | Labelling blood cells |
GB8603778D0 (en) * | 1986-02-15 | 1986-03-19 | Beecham Group Plc | Chemical process |
DE3631013A1 (de) * | 1986-09-12 | 1988-03-24 | Thomae Gmbh Dr K | Neue naphthylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
US4933156A (en) | 1987-04-08 | 1990-06-12 | Salutar, Inc. | Amyloidosis and Alzheimer's disease diagnostic assay and reagents therefor |
US5008099A (en) | 1987-04-08 | 1991-04-16 | Salutar, Inc. | Amyloidosis and Alzheimer's disease diagnostic assay and reagents therefor |
CN1072020A (zh) | 1991-10-28 | 1993-05-12 | 国营八二一厂 | 多用途血液稀释剂 |
US5690904A (en) | 1993-07-12 | 1997-11-25 | Amersham International Plc | Diagnostic radiopharmaceutical compounds (That) |
US6168776B1 (en) | 1994-07-19 | 2001-01-02 | University Of Pittsburgh | Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
US6417178B1 (en) | 1994-07-19 | 2002-07-09 | University Of Pittsburgh | Amyloid binding nitrogen-linked compounds for the antemortem diagnosis of alzheimer's disease, in vivo imaging and prevention of amyloid deposits |
US5955472A (en) | 1995-11-02 | 1999-09-21 | Warner-Lambert Company | Naphthylazo inhibition of amyloidosis |
US6274119B1 (en) | 1998-08-20 | 2001-08-14 | The Regents Of The Univ. Of California | Methods for labeling β-amyloid plaques and neurofibrillary tangles |
TW438596B (en) | 1999-02-26 | 2001-06-07 | Inst Of Nuclear Energy Res Roc | Preparation of a new technetium-99m radiopharmaceutical kit for dopamine transporter imaging |
DE10018199A1 (de) * | 2000-04-12 | 2001-10-31 | Few Chemicals Gmbh | Fluoreszenzmarker |
IT1317048B1 (it) | 2000-06-23 | 2003-05-26 | Sigma Tau Ind Farmaceuti | Uso dell'acido pamoico o di un suo derivato, o di un suo analogo, perla preparazione di un medicamento per il trattamento di patologie |
GB0023467D0 (en) * | 2000-09-25 | 2000-11-08 | Btg Int Ltd | Amine compounds |
US6379650B1 (en) | 2001-03-19 | 2002-04-30 | Wesley Scott Ashton | Technetium 99m-N2S2-congo red complexes utilizing diamide dithiolate ligand systems for radioimaging |
GB0106953D0 (en) | 2001-03-20 | 2001-05-09 | Univ Aberdeen | Neufofibrillary labels |
AU2002258915B2 (en) | 2001-04-23 | 2007-11-15 | The Trustees Of The University Of Pennsylvania | Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
CA2446716A1 (en) * | 2001-06-05 | 2002-12-12 | Eli Lilly And Company | Sulfonamide derivatives |
EP1432453B1 (en) | 2001-08-27 | 2013-08-14 | The Trustees of The University of Pennsylvania | Stilbene derivatives and their use for binding and imaging amyloid plaques |
AU2003272680A1 (en) * | 2002-09-23 | 2004-04-08 | Chromagen, Inc. | Novel green and orange fluorescent labels and their uses |
JP2007504283A (ja) | 2003-05-20 | 2007-03-01 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | β−アミロイド斑に作用物質を結合させる方法 |
EP1718656A2 (en) * | 2004-02-10 | 2006-11-08 | Purdue Research Foundation | Crowned dithiocarbamate metal complexes and methods for their use |
US7803351B2 (en) | 2004-08-20 | 2010-09-28 | Washington University | Blood brain barrier permeation peptides |
WO2006083378A2 (en) | 2004-11-29 | 2006-08-10 | The Regents Of The University Of California | IN VIVO MONITORING OF β-AMYLOID PLAQUES AND NEUROFIBRILLARY TANGLES |
SI2213652T1 (sl) | 2004-12-17 | 2015-03-31 | The Trustees Of The University Of Pennsylvania | Derivati stilbena in njihova uporaba za vezavo in prikaz amiloidnih plakov |
JPWO2006115137A1 (ja) * | 2005-04-22 | 2008-12-18 | キッセイ薬品工業株式会社 | 2−アミノベンズイミダゾール誘導体及びその医薬用途 |
AU2006303301A1 (en) | 2005-10-18 | 2007-04-26 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Naphthyl derivatives as inhibitors of beta-amyloid aggregation |
CA2730485A1 (en) * | 2006-01-30 | 2007-08-07 | University Of North Dakota | Divalent metal ion sensors and binders |
US8337941B2 (en) * | 2006-07-27 | 2012-12-25 | The Trustees Of Columbia University In The City Of New York | Fluorescent substrates for monoamine transporters as optical false neurotransmitters |
JP2011507910A (ja) * | 2007-12-21 | 2011-03-10 | ユニバーシティー オブ ロチェスター | 真核生物の寿命を変更するための方法 |
GB0819280D0 (en) * | 2008-10-21 | 2008-11-26 | Gen Electric | Imgaing and radiotherapy methods |
-
2009
- 2009-04-17 CU CU2009000057A patent/CU23844B1/es active IP Right Grant
-
2010
- 2010-04-17 ES ES14075021.7T patent/ES2692072T3/es active Active
- 2010-04-17 PL PL10764119T patent/PL2436666T3/pl unknown
- 2010-04-17 EP EP14075021.7A patent/EP2860169B1/en active Active
- 2010-04-17 US US13/574,050 patent/US9764047B2/en active Active
- 2010-04-17 WO PCT/CU2010/000001 patent/WO2010118706A2/es active Application Filing
- 2010-04-17 PT PT107641193T patent/PT2436666E/pt unknown
- 2010-04-17 ES ES10764119.3T patent/ES2478442T3/es active Active
- 2010-04-17 HU HUE14075021A patent/HUE042030T2/hu unknown
- 2010-04-17 MX MX2011013405A patent/MX2011013405A/es active IP Right Grant
- 2010-04-17 DK DK10764119.3T patent/DK2436666T3/da active
- 2010-04-17 EP EP10764119.3A patent/EP2436666B1/en active Active
- 2010-04-17 CA CA2789869A patent/CA2789869C/en active Active
- 2010-04-17 SI SI201030668T patent/SI2436666T1/sl unknown
- 2010-04-17 MX MX2013011331A patent/MX338943B/es unknown
- 2010-04-17 BR BR122020016643A patent/BR122020016643B8/pt active IP Right Grant
- 2010-04-17 MY MYPI2012003534A patent/MY162719A/en unknown
- 2010-04-17 BR BRPI1014595-8A patent/BRPI1014595B1/pt active IP Right Grant
-
2014
- 2014-07-01 HR HRP20140628AT patent/HRP20140628T1/hr unknown
- 2014-08-29 SM SM201400118T patent/SMT201400118B/xx unknown
-
2015
- 2015-03-03 US US14/636,316 patent/US10155053B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
DK2436666T3 (da) | 2014-07-14 |
PL2436666T3 (pl) | 2014-09-30 |
US10155053B2 (en) | 2018-12-18 |
HUE042030T2 (hu) | 2019-06-28 |
HRP20140628T1 (hr) | 2014-11-21 |
EP2436666A2 (en) | 2012-04-04 |
MX2011013405A (es) | 2012-10-23 |
US20120321560A1 (en) | 2012-12-20 |
BR122020016643B1 (pt) | 2021-03-30 |
MY162719A (en) | 2017-07-14 |
ES2692072T3 (es) | 2018-11-30 |
ES2478442T3 (es) | 2014-07-22 |
US20150217005A1 (en) | 2015-08-06 |
PT2436666E (pt) | 2014-07-18 |
CA2789869A1 (en) | 2010-10-21 |
EP2436666A4 (en) | 2013-02-13 |
SI2436666T1 (sl) | 2014-09-30 |
WO2010118706A3 (es) | 2010-12-02 |
EP2860169B1 (en) | 2018-08-29 |
EP2860169A3 (en) | 2015-10-21 |
BR122020016643B8 (pt) | 2021-07-27 |
BRPI1014595B1 (pt) | 2021-07-06 |
SMT201400118B (it) | 2014-11-10 |
US9764047B2 (en) | 2017-09-19 |
WO2010118706A2 (es) | 2010-10-21 |
EP2436666B1 (en) | 2014-04-09 |
BRPI1014595A2 (pt) | 2016-04-05 |
WO2010118706A4 (es) | 2011-01-20 |
CA2789869C (en) | 2016-06-21 |
EP2860169A2 (en) | 2015-04-15 |
MX338943B (es) | 2016-05-06 |
CU20090057A6 (es) | 2011-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CU23844B1 (es) | Procedimiento de obtención de nuevos derivados de naftaleno para el diagnóstico in vivo de la enfermedad de alzheimer | |
ECSP088645A (es) | Nuevos benzotiazoles sustituidos con heteroaril | |
DOP2006000084A (es) | Compuestos sulfoximino-macrociclicos y sus sales, composiciones farmaceuticas que comprenden dichos compuestos, metodos de preparacion y usos de los mismos | |
BRPI0617151B8 (pt) | composto, multímero, composto vetorizado, complexo do referido composto, bem como composições farmacêutica, farmacêutica lipídica e de diagnóstico para imagiologia por ressonância magnética e processo para a preparação de um complexo metálico | |
ECSP109910A (es) | Derivados de n-(arilamino) sulfonamidas que incluyen polimorfos como inhibidores de mek así como composiciones, métodos de uso y de preparación de los mismos | |
CY1110137T1 (el) | Συμπυκνωμενες τρικυκλικες ενωσεις peri χρησιμες ως αντιβακτηριακοι παραγοντες | |
CO7141456A2 (es) | Derivados de aril-sultamo como moduladores de rorc | |
ECSP088587A (es) | Compuestos de piperidina 3,5-sustituida como inhibidores de renina | |
GT200500102A (es) | Compuestos de aril-o-heteroarilamida ortosustituidos | |
RU2014145281A (ru) | Фотодинамические тиофены на основе металла и их применение | |
CY1118390T1 (el) | Θεραπευτικος παραγων για τη φλεγμονωδη νοσο του εντερου | |
DOP2005000071A (es) | "compuestos de metil-aril o heteroaril-amida sustituida" | |
PE20160159A1 (es) | Derivados de diazacarbazol como ligandos de tau para pet | |
CO6351754A2 (es) | Agentes de contraste que comprenden compuestos fenilo yodados | |
DOP2006000017A (es) | Pirazolopiridinas y sales de las mismas, una composición farmaceútica que comprende dichos compuestos, un método para prepararlos y su uso | |
BRPI0808503B8 (pt) | composto, uso de um composto, e, composição farmacêutica | |
AR114029A2 (es) | Compuestos adecuados como precursores de compuestos que son útiles para obtener imágenes de depósitos amiloides, usos y procesos | |
CO6561809A2 (es) | Composiciones antimicrobianas líquidas | |
PE20121187A1 (es) | Canfenos arilados con actividad sobre los receptores cb2 y procesos para su preparacion | |
AR079294A1 (es) | Acidos homoglutamico y acidos glutamico marcados con yodo y metodo de preparacion de los mismos | |
RU2008152751A (ru) | Соли тримебутина и n-десметилтримебутина | |
CU20130027A7 (es) | Chaperoninas químicas como nuevos moduladores moleculares de la beta agregación proteica presente en las enfermedades conformacionales | |
CU20100204A7 (es) | Procedimientos de obtención de nuevos derivados de naftaleno para el diagnóstico in vivo de la enfermedad de alzheimer | |
JP2017101118A5 (es) | ||
BRPI0808090A2 (pt) | Composto, composição farmacêutica, e, método in vivo para medir depósitos de amilóide em um paciente |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant of patent |